Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 26, 2017

Pakdeljam v. Intra-Cellular Therapies, Inc. et al

Track this case

Case Number:

1:17-cv-03197

Court:

New York Eastern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Nina Gershon

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 30, 2017

    Intra-Cellular Hid Drug Issues Before FDA Probe, Suit Says

    A putative class of Intra-Cellular Therapies Inc. investors on Friday in New York federal court accused the biopharmaceutical company of concealing safety concerns about its new schizophrenia medication lumateperone, saying that stock prices dropped after the U.S. Food and Drug Administration questioned the drug's effect on animals.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login